Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. GOOGL
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients
PACIRA (NASDAQ: PCRX) Delayed: 22.71 +0.38 (1.70%)
Previous Close $22.33    52 Week High $80.25 
Open $22.21    52 Week Low $30.25 
Day High $22.84    P/E N/A 
Day Low $22.00    EPS $-2.08 
Volume 706,850       

PACIRA (NASDAQ: PCRX) Delayed: 22.71 +0.38 (1.70%)
Previous Close $22.33    52 Week High $80.25 
Open $22.21    52 Week Low $30.25 
Day High $22.84    P/E N/A 
Day Low $22.00    EPS $-2.08 
Volume 706,850